{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:13:34Z","timestamp":1792872814461,"version":"4.5.0"},"reference-count":205,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.autrev.2022.103036","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:13:41Z","timestamp":1641298421000},"page":"103036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Mucous membrane pemphigoid"],"prefix":"10.1016","volume":"21","author":[{"given":"Gefei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Patzelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103036_bb0005","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J Europ Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.autrev.2022.103036_bb0010","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Europ Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.autrev.2022.103036_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103036_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0025","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I","volume":"35(9)","author":"Rashid","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.autrev.2022.103036_bb0030","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0035","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0040","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0190-9622(91)70159-Y","article-title":"Cicatricial pemphigoid","volume":"24","author":"Ahmed","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","article-title":"Mucous membrane pemphigoid and pseudopemphigoid","volume":"111","author":"Thorne","year":"2004","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb0050","series-title":"Rook\u2019s Textbook of Dermatology, part 3, chapter 50","article-title":"Immunobullous disorders","author":"Schmidt","year":"2022"},{"key":"10.1016\/j.autrev.2022.103036_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12026-019-09087-7","article-title":"Ocular mucous membrane pemphigoid: a review","volume":"67","author":"Taurone","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2022.103036_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/ICU.0000000000000517","article-title":"Ocular cicatricial pemphigoid","volume":"29","author":"Wang","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103036_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine."},{"key":"10.1016\/j.autrev.2022.103036_bb0070","series-title":"Management of blistering diseases","first-page":"1","article-title":"Historical background","author":"Holubar","year":"1990"},{"key":"10.1016\/j.autrev.2022.103036_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0080","first-page":"175","article-title":"Pemphigus of the skin and mucous membranes","volume":"1","author":"Morris","year":"1889","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0085","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.autrev.2022.103036_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous diseases French study group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.1995.01690200097021","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0100","first-page":"434","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2022.103036_bb0105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jdv.17107","article-title":"Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases","volume":"35","author":"van Beek","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/eye.2012.119","article-title":"Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom","volume":"26","author":"Radford","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.autrev.2022.103036_bb0115","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41433-018-0155-7","article-title":"Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand","volume":"32","author":"Bobba","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.autrev.2022.103036_bb0120","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany","volume":"136","author":"Hubner","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","article-title":"Cicatricial pemphigoid","volume":"25","author":"Ahmed","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0030-4220(82)90080-9","article-title":"Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases","volume":"54","author":"Laskaris","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.autrev.2022.103036_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.oooo.2015.01.024","article-title":"World workshop on oral medicine VI: a systematic review of the treatment of mucous membrane pemphigoid","volume":"120","author":"Taylor","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.autrev.2022.103036_bb0140","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3389\/fimmu.2019.02219","article-title":"A retrospective study of patient-reported data of bullous pemphigoid and mucous membrane pemphigoid from a US-based registry","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.md.0000231954.08350.52","article-title":"A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid","volume":"85","author":"Alexandre","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103036_bb0150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/ced.13996","article-title":"Mucous membrane pemphigoid and oral blistering diseases","volume":"44","author":"Carey","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0155","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/jdv.16467","article-title":"Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany","volume":"34","author":"Hubner","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0160","series-title":"Harper\u2019s textbook of pediatric dermatology, chapter 73","first-page":"868","article-title":"Autoimmune bullous diseases","author":"van Beek","year":"2020"},{"key":"10.1016\/j.autrev.2022.103036_bb0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1601-0825.2005.01140.x","article-title":"Mucosal disease series. Number III. Mucous membrane pemphigoid","volume":"11","author":"Bagan","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2022.103036_bb0170","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103036_bb0175","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0190-9622(91)70299-H","article-title":"Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis?","volume":"25","author":"Nayar","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0180","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1073\/pnas.91.16.7747","article-title":"Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid","volume":"91","author":"Yunis","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103036_bb0185","first-page":"330","article-title":"HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians","volume":"8","author":"Drouet","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2133.2001.04380.x","article-title":"Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production","volume":"145","author":"Setterfield","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2133.2001.04448.x","article-title":"HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity","volume":"145","author":"Carrozzo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1523-1747.ep12332352","article-title":"Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0205","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3109\/02713689208999549","article-title":"Report on the sequence of DQB1*0301 gene in ocular cicatricial pemphigoid patients","volume":"11","author":"Haider","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.autrev.2022.103036_bb0210","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.88.24.11579","article-title":"Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103036_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bjo.62.4.265","article-title":"HLA antigens in ocular cicatricial pemphigoid","volume":"62","author":"Mondino","year":"1978","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103036_bb0220","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/exd.13464","article-title":"Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid","volume":"26","author":"Sadik","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2230.2009.03222.x","article-title":"Coexistence of mucous membrane pemphigoid and connective-tissue disease","volume":"35","author":"Malik","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0230","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0235","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103036_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2004.tb00497.x","article-title":"A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy","volume":"31","author":"Matsushima","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0245","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2011.10474.x","article-title":"Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients","volume":"165","author":"Terra","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0250","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.oooo.2013.12.402","article-title":"Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing","volume":"117","author":"Hayakawa","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.autrev.2022.103036_bb0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bjd.17202","article-title":"A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid","volume":"180","author":"Goletz","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0260","article-title":"Anti-laminin 332 antibody detection using biochip immunofluorescence microscopy in a real-life cohort of Italian patients with mucous membrane pemphigoid","author":"Gasparini","year":"2021","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjd.20099","article-title":"Clinical and immunological findings in 55 patients with anti-laminin 332-type mucous membrane pemphigoid","volume":"185","author":"Li","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0270","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2022.103036_bb0275","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0280","article-title":"Evaluation of site- and autoantigen-specific characteristics of mucous membrane pemphigoid","author":"van Beek","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0285","unstructured":"Goletz S, Giurdanella F, Holtsche MM, Nijenhuis AM, Horvath B, Diercks GF, et al. Comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid. Front Immunol in press."},{"key":"10.1016\/j.autrev.2022.103036_bb0290","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.matbio.2009.07.008","article-title":"Defining the role of laminin-332 in carcinoma","volume":"28","author":"Guess","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2022.103036_bb0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2019.09.026","article-title":"Laminin 332 in cancer: when the extracellular matrix turns signals from cell anchorage to cell movement","volume":"62","author":"Rousselle","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.autrev.2022.103036_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.1991.tb06077.x","article-title":"No association between cicatricial pemphigoid and malignant disease","volume":"125","author":"Nayar","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0305","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2230.2007.02463.x","article-title":"Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit","volume":"32","author":"Letko","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2006.00483.x","article-title":"Relationship between cancer and oral pemphigoid patients with antibodies to alpha6-integrin","volume":"36","author":"Malik","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2022.103036_bb0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/odi.12193","article-title":"Urban legend series: mucous membrane pemphigoid","volume":"20","author":"Di Zenzo","year":"2014","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2022.103036_bb0320","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2022.103036_bb0325","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.13446","article-title":"Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases","volume":"26","author":"Goletz","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0330","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12616580","article-title":"Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180","volume":"99","author":"Giudice","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","article-title":"Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid","volume":"17","author":"Murakami","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0340","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0345","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2133.2000.03598.x","article-title":"The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis","volume":"143","author":"Roh","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0350","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","article-title":"Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain","volume":"106","author":"Balding","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0360","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida","volume":"108","author":"Bedane","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0923-1811(01)00144-X","article-title":"Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain","volume":"28","author":"Kromminga","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(03)00035-5","article-title":"Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180","volume":"32","author":"Lee","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0375","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/jop.12780","article-title":"The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes","volume":"48","author":"Kamaguchi","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.autrev.2022.103036_bb0380","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1111\/bjd.15925","article-title":"Oral mucosa is a useful substrate for detecting autoantibodies of mucous membrane pemphigoid","volume":"178","author":"Kamaguchi","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0385","first-page":"762","article-title":"Clinical and immunological studies of 332 Japanese patients tentatively diagnosed as Anti-BP180-type mucous membrane pemphigoid: a Novel BP180 C-terminal domain enzyme-linked immunosorbent assay","volume":"96","author":"Yasukochi","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jdermsci.2017.07.005","article-title":"Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay","volume":"88","author":"Izumi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0395","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2133.2009.09566.x","article-title":"Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses","volume":"162","author":"Grootenboer-Mignot","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0400","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/bjd.14351","article-title":"Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid","volume":"174","author":"Ali","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0405","first-page":"768","article-title":"Autoantibody profile of a cohort of 78 Italian patients with mucous membrane pemphigoid: correlation between reactivity profile and clinical involvement","volume":"96","author":"Cozzani","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0410","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1523-1747.ep12876206","article-title":"Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis","volume":"94","author":"Bernard","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0415","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1902\/jop.2004.75.10.1302","article-title":"Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity","volume":"75","author":"Carrozzo","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.autrev.2022.103036_bb0420","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1523-1747.ep12616797","article-title":"The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen","volume":"99","author":"Bernard","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0425","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","article-title":"IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis","volume":"143","author":"Christophoridis","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0430","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2006.10.007","article-title":"Oral pemphigoid autoantibodies preferentially target BP180 ectodomain","volume":"122","author":"Calabresi","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0435","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103036_bb0440","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","article-title":"Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA","volume":"124","author":"Bekou","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0445","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1523-1747.ep12292578","article-title":"Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0450","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horvath","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0455","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2133.1999.02816.x","article-title":"Characterization of the antibody response in oesophageal cicatricial pemphigoid","volume":"140","author":"Egan","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0460","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2004.04.010","article-title":"Profile of autoantibody to basement membrane zone proteins in patients with mucous membrane pemphigoid: long-term follow up and influence of therapy","volume":"112","author":"Yeh","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0465","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/1346-8138.13361","article-title":"Mucous membrane pemphigoid reactive only with BP230","volume":"43","author":"Inoue","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0470","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0475","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/00220345010800080601","article-title":"Autoantibodies to human alpha6 integrin in patients with oral pemphigoid","volume":"80","author":"Bhol","year":"2001","journal-title":"J Dent Res"},{"key":"10.1016\/j.autrev.2022.103036_bb0480","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1684\/ejd.2016.2772","article-title":"Integrin \u03b24 is a major target antigen in pure ocular mucous membrane pemphigoid","volume":"26","author":"Li","year":"2016","journal-title":"Europ J Dermatol EJD"},{"key":"10.1016\/j.autrev.2022.103036_bb0485","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00441-015-2216-6","article-title":"Molecular architecture and function of the hemidesmosome","volume":"360","author":"Walko","year":"2015","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2022.103036_bb0490","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/1523-1747.ep12366078","article-title":"Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid","volume":"101","author":"Smith","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0495","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/1523-1747.ep12298424","article-title":"Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid","volume":"107","author":"Ghohestani","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0500","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0190-9622(91)70152-R","article-title":"Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies","volume":"24","author":"Sarret","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0505","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/1523-1747.ep12480369","article-title":"The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita","volume":"97","author":"Bernard","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0510","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1365-2133.1998.02168.x","article-title":"Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease","volume":"138","author":"Setterfield","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0515","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2133.1999.02763.x","article-title":"Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity","volume":"140","author":"Setterfield","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0520","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jid.2018.03.002","article-title":"High expression of collagen XVII compensates for its depletion induced by pemphigoid igg in the oral Mucosa","volume":"138","author":"Kamaguchi","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0525","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41374-018-0113-9","article-title":"The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies","volume":"99","author":"Kamaguchi","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2022.103036_bb0530","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1365-2133.2004.06219.x","article-title":"Rapid effector function of circulating NC16A-specific T cells in individuals with mucous membrane pemphigoid","volume":"151","author":"Black","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0535","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00130832-200410000-00017","article-title":"Ocular cicatricial pemphigoid review","volume":"4","author":"Foster","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103036_bb0540","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.2353\/ajpath.2009.090579","article-title":"Conjunctival Interleukin-13 expression in mucous membrane pemphigoid and functional effects of Interleukin-13 on conjunctival fibroblasts in vitro","volume":"175","author":"Saw","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2022.103036_bb0545","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1167\/iovs.08-3345","article-title":"Tumor necrosis factor-alpha in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts","volume":"50","author":"Saw","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0550","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2016.284","article-title":"The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on","volume":"31","author":"Dart","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.autrev.2022.103036_bb0555","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.4049\/jimmunol.176.3.1968","article-title":"Identification of an epitope within human integrin alpha 6 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid","volume":"176","author":"Rashid","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0560","first-page":"2283","article-title":"The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid","volume":"40","author":"Chan","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0565","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/clim.2000.4972","article-title":"In vitro organ culture model for mucous membrane pemphigoid","volume":"98","author":"Colon","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0570","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1172\/JCI118942","article-title":"Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice","volume":"98","author":"Lazarova","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2022.103036_bb0575","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/clim.2000.4845","article-title":"Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice","volume":"95","author":"Lazarova","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0580","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1523-1747.2000.00829.x","article-title":"Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model","volume":"114","author":"Lazarova","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0585","first-page":"585","article-title":"The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease","volume":"10","author":"Egan","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0590","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2009.02.012","article-title":"Histopathology of anti-laminin 5 mucous membrane pemphigoid","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0595","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","article-title":"Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease","volume":"137","author":"Heppe","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2022.103036_bb0600","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jid.2021.04.009","article-title":"Dapsone suppresses disease in preclinical murine models of pemphigoid diseases","volume":"141","author":"Murthy","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0605","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0610","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jid.2016.07.040","article-title":"Targeted disruption of the Lama3 gene in adult mice is sufficient to induce skin inflammation and fibrosis","volume":"137","author":"Pesch","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0615","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-62703-227-8_25","article-title":"Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII","volume":"961","author":"Sesarman","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.autrev.2022.103036_bb0620","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","article-title":"Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice","volume":"187","author":"Hirose","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0625","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/jid.2010.248","article-title":"Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita","volume":"131","author":"Ludwig","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2022.103036_bb0630","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1167\/iovs.12-11404","article-title":"Identification of epitopes within integrin beta4 for binding of autoantibodies in ocular cicatricial and mucous membrane pemphigoid-preliminary report","volume":"54","author":"Rashid","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2022.103036_bb0635","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1079-2104(99)70194-0","article-title":"Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity","volume":"88","author":"Scully","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.autrev.2022.103036_bb0640","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jid.2017.01.028","article-title":"Meeting report of the pathogenesis of pemphigus and pemphigoid meeting in Munich, September 2016","volume":"137","author":"Schmidt","year":"2017","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0645","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1111\/jdv.16217","article-title":"Mucous membrane pemphigoid involving the urethra: a case series","volume":"34","author":"Orfaly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0650","article-title":"Mucous membrane pemphigoid of the anal canal resulting in anal stricture","author":"Chapman","year":"2020","journal-title":"Am Surg"},{"key":"10.1016\/j.autrev.2022.103036_bb0655","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2340\/00015555-1659","article-title":"A case of mucous membrane pemphigoid involving the trachea and bronchus with autoantibodies to \u03b23 subunit of laminin-332","volume":"94","author":"Kato","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0660","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cden.2004.07.004","article-title":"Mucous membrane pemphigoid","volume":"49","author":"Sollecito","year":"2005","journal-title":"Dent Clin N Am"},{"key":"10.1016\/j.autrev.2022.103036_bb0665","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cden.2013.07.003","article-title":"Mucous membrane pemphigoid","volume":"57","author":"Xu","year":"2013","journal-title":"Dent Clin N Am"},{"key":"10.1016\/j.autrev.2022.103036_bb0670","first-page":"e149","article-title":"Describing the gingival involvement in a sample of 182 Italian predominantly oral mucous membrane pemphigoid patients: a retrospective series","volume":"22","author":"Arduino","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.autrev.2022.103036_bb0675","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1601-5037.2011.00527.x","article-title":"Professional oral hygiene treatment and detailed oral hygiene instructions in patients affected by mucous membrane pemphigoid with specific gingival localization: a pilot study in 12 patients","volume":"10","author":"Arduino","year":"2012","journal-title":"Int J Dent Hyg"},{"key":"10.1016\/j.autrev.2022.103036_bb0680","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1365-4632.2009.04142.x","article-title":"Epidemiology of desquamative gingivitis: evaluation of 125 patients and review of the literature","volume":"48","author":"Lo Russo","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/odi.13083","article-title":"World workshop of oral medicine VII: a systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus","volume":"25","author":"Mays","year":"2019","journal-title":"Oral Dis"},{"key":"10.1016\/j.autrev.2022.103036_bb0690","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1542-0124(12)70281-1","article-title":"Ocular mucous membrane pemphigoid: diagnosis and management strategies","volume":"6","author":"Saw","year":"2008","journal-title":"Ocul Surf"},{"key":"10.1016\/j.autrev.2022.103036_bb0695","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.autrev.2019.02.005","article-title":"Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy","volume":"18","author":"Buonavoglia","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"253\u201361","key":"10.1016\/j.autrev.2022.103036_bb0700","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb0705","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40123-019-0164-z","article-title":"Ocular mucous membrane pemphigoid: current state of pathophysiology, diagnostics and treatment","volume":"8","author":"Georgoudis","year":"2019","journal-title":"Ophthalmol Therapy"},{"key":"10.1016\/j.autrev.2022.103036_bb0710","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/ICU.0b013e328358bafd","article-title":"Mucous membrane pemphigoid","volume":"23","author":"Srikumaran","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2022.103036_bb0715","first-page":"3379","article-title":"Ocular cicatricial pemphigoid (review)","volume":"20","author":"Branisteanu","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.autrev.2022.103036_bb0720","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cden.2013.07.003","article-title":"Mucous membrane pemphigoid","volume":"57","author":"Xu","year":"2013","journal-title":"Dent Clin N Am"},{"key":"10.1016\/j.autrev.2022.103036_bb0725","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2022.103036_bb0730","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/jdv.15679","article-title":"Review of autoimmune blistering diseases: the Pemphigoid diseases","volume":"33","author":"Daniel","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0735","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00405-020-05812-3","article-title":"Mucous membrane pemphigoid\u2013otorhinolaryngological manifestations: a retrospective cohort study","volume":"277","author":"Madgar","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.autrev.2022.103036_bb0740","first-page":"101","article-title":"Vulvar involvement in autoimmune bullous diseases","volume":"38","author":"Marren","year":"1993","journal-title":"J Reprod Med"},{"key":"10.1016\/j.autrev.2022.103036_bb0745","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/LBR.0000000000000374","article-title":"Mucous membrane pemphigoid causing central airway obstruction","volume":"24","author":"Jalil","year":"2017","journal-title":"J Bronchol Intervent Pulmonol"},{"key":"10.1016\/j.autrev.2022.103036_bb0750","first-page":"5749784","article-title":"Mucous membrane pemphigoid with tracheal involvement","volume":"2016","author":"Minaie","year":"2016","journal-title":"Case Rep Pulmonol"},{"key":"10.1016\/j.autrev.2022.103036_bb0755","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.ico.0000178730.34564.c7","article-title":"Mucous membrane pemphigoid with fatal bronchial involvement in a seventeen-year-old girl","volume":"25","author":"Gamm","year":"2006","journal-title":"Cornea."},{"key":"10.1016\/j.autrev.2022.103036_bb0760","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","article-title":"Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts","volume":"72","author":"Murrell","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0765","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1346-8138.12711","article-title":"Outcome measures for autoimmune blistering diseases","volume":"42","author":"Zhao","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0770","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/bjd.16265","article-title":"An oral disease severity score validated for use in oral pemphigus vulgaris","volume":"179","author":"Ormond","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0775","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","article-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","volume":"89","author":"Foster","year":"1982","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb0780","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb0785","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9394(77)90546-3","article-title":"Autoimmune phenomena in ocular cicatricial pemphigoid","volume":"83","author":"Mondino","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103036_bb0790","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","article-title":"Immunosuppressive therapy in ocular cicatricial pemphigoid","volume":"96","author":"Mondino","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103036_bb0795","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00003226-199209000-00015","article-title":"Improved detection of disease progression in ocular cicatricial pemphigoid","volume":"11","author":"Tauber","year":"1992","journal-title":"Cornea."},{"key":"10.1016\/j.autrev.2022.103036_bb0800","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtos.2019.10.010","article-title":"Validation of a clinical assessment tool for cicatrising conjunctivitis","volume":"18","author":"Ong","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.autrev.2022.103036_bb0805","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/bjd.18032","article-title":"The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris","volume":"182","author":"Carey","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0810","series-title":"Diseases of the oral mucosa","article-title":"Mucous membrane pemphigoid","author":"Lamberts","year":"2021"},{"key":"10.1016\/j.autrev.2022.103036_bb0815","first-page":"3379","article-title":"Ocular cicatricial pemphigoid (review)","volume":"20","author":"Branisteanu","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.autrev.2022.103036_bb0820","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.4103\/ijo.IJO_604_20","article-title":"Chronic cicatrizing conjunctivitis: a review of the differential diagnosis and an algorithmic approach to management","volume":"68","author":"Vazirani","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103036_bb0825","first-page":"1","article-title":"Reliability of conjunctival biopsy for diagnosis of ocular mucous membrane pemphigoid: redetermination of the standard for diagnosis and outcomes of previously biopsy-negative patients","author":"Anesi","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.autrev.2022.103036_bb0830","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamadermatol.2021.1036","article-title":"Assessment of diagnostic strategy for mucous membrane pemphigoid","volume":"157","author":"Rashid","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0835","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2017.05.016","article-title":"Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid","volume":"77","author":"Shimanovich","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0840","doi-asserted-by":"crossref","DOI":"10.5070\/D32110028946","article-title":"IgM ocular cicatricial pemphigoid: a unique insight into the immune system","volume":"21","author":"Tazudeen","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.autrev.2022.103036_bb0845","first-page":"1268","article-title":"Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid","volume":"13","author":"Mehra","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2022.103036_bb0850","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.12308","article-title":"The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0855","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3748","article-title":"Diagnostic value and practicability of serration pattern analysis by direct immunofluorescence microscopy in pemphigoid diseases","volume":"101","author":"Holtsche","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"754\u20139","key":"10.1016\/j.autrev.2022.103036_bb0860","article-title":"Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases","volume":"78","author":"Meijer","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0865","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archderm.1996.03890260053008","article-title":"Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping","volume":"132","author":"De Jong","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0870","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archderm.139.8.1007","article-title":"A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy","volume":"139","author":"Wozniak","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0875","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archderm.1997.03890450048006","article-title":"Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses","volume":"133","author":"Ghohestani","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0880","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","article-title":"The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid","volume":"118","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0885","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaad.2019.03.077","article-title":"Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin","volume":"81","author":"Lau","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0890","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0895","first-page":"e224","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103036_bb0900","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0905","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","article-title":"Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0910","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.18129","article-title":"Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases","volume":"182","author":"Giurdanella","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0915","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaad.2004.06.004","article-title":"Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid","volume":"51","author":"Lazarova","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0920","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1067\/mjd.2003.99","article-title":"Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy","volume":"48","author":"Vodegel","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0925","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2011.10776.x","article-title":"Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen","volume":"166","author":"Hayashi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0930","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.2009.09508.x","article-title":"Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid","volume":"162","author":"Natsuga","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0935","doi-asserted-by":"crossref","first-page":"14714","DOI":"10.1073\/pnas.93.25.14714","article-title":"Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization","volume":"93","author":"Tyagi","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103036_bb0940","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1684\/ejd.2016.2772","article-title":"Integrin beta4 is a major target antigen in pure ocular mucous membrane pemphigoid","volume":"26","author":"Li","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0945","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ophtha.2020.07.052","article-title":"Autoantibody detection for diagnosis in direct immunofluorescence-negative mucous membrane pemphigoid: ocular and other sites compared","volume":"128","author":"Dart","year":"2021","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb0950","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bjo.2006.092528","article-title":"Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa","volume":"90","author":"Higgins","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2022.103036_bb0955","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.1971.04000230009002","article-title":"Benign mucous membrane pemphigoid","volume":"104","author":"Hardy","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0960","first-page":"54","article-title":"Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations","volume":"52","author":"Person","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2022.103036_bb0965","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199105000-00001","article-title":"Systemic chemotherapy for ocular cicatricial pemphigoid","volume":"10","author":"Tauber","year":"1991","journal-title":"Cornea."},{"key":"10.1016\/j.autrev.2022.103036_bb0970","first-page":"e136","article-title":"Oral hygiene instructions and professional control as part of the treatment of desquamative gingivitis. Systematic review","volume":"24","author":"Garcia-Pola","year":"2019","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.autrev.2022.103036_bb0975","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2016.10.028","article-title":"Periodontitis in oral pemphigus and pemphigoid: a systematic review of published studies","volume":"76","author":"Jascholt","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0980","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/ICO.0000000000000168","article-title":"Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients","volume":"33","author":"Friedman","year":"2014","journal-title":"Cornea."},{"key":"10.1016\/j.autrev.2022.103036_bb0985","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","article-title":"Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy","volume":"115","author":"Thorne","year":"2008","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb0990","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaad.2016.01.020","article-title":"Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP)","volume":"74","author":"Maley","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2022.103036_bb0995","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","article-title":"Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up","volume":"111","author":"Sami","year":"2004","journal-title":"Ophthalmology."},{"key":"10.1016\/j.autrev.2022.103036_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102799","article-title":"Crossreactivity: the possible role of oral microbiota in oral mucous membrane pemphigoid","volume":"20","author":"Lucchese","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103036_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102761","article-title":"Engineered antigen-specific regulatory T cells for autoimmune skin conditions","volume":"20","author":"Mukhatayev","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103036_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102852","article-title":"MicroRNAs in pemphigus and pemphigoid diseases","volume":"20","author":"Papara","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103036_bb1015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103036_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102528","article-title":"12\/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation","volume":"115","author":"Sezin","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103036_bb1025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaut.2012.04.002","article-title":"Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen","volume":"39","author":"Hirose","year":"2012","journal-title":"J Autoimmun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:24:26Z","timestamp":1761600266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":205,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1568997222000064"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103036","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucous membrane pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103036"}}